TORONTO (Reuters) - Canada could approve one or more COVID-19 vaccines early in the first quarter of 2021, under a new, accelerated process similar to the U.S. emergency use authorization, according to Health Canada, the country's drug regulator.
An interim order signed by Canada's health minister on Sept. 16 created an expedited, temporary review system for COVID-19 drugs or vaccines, which otherwise could have taken a year to evaluate.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!